Prior reports have described an upregulation of P2RX7 mRNA (McLarnon et al., 2006) and protein (Martin et al., 2019, di Lauro et al., 2022) in end-stage AD relative to non-demented controls, however changes were not related to Braak stage. Here, P2RX7 is linked to Alzheimer disease.